Genomics and general practice: The next 10 years

Australian Family Physician

Volumn 39, Issue 5, 2010, Pages 339-340

  Leung, Lawrence ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

General practice; Genomics; Preventive medicine

Indexed keywords

CANADA; CLINICAL PRACTICE; FEMALE; FORECASTING; GENERAL PRACTICE; GENOMICS; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; NOTE; PREVENTIVE MEDICINE; STANDARD; STANDARDS; TRENDS;

ATTITUDE OF HEALTH PERSONNEL; CANADA; FAMILY PRACTICE; FEMALE; FORECASTING; GENOMICS; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PREVENTIVE MEDICINE;

EID: 77957243852     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (22)

1. Kasper CE. Genomics and proteomics methodologies for vulnerable populations research. Annu Rev Nurs Res 2007;25:191-217.
2. Robbins G, Tripathy VM, Misra VN, et al. Ancient skeletal evidence for leprosy in India (2000 BC). PLoS One 2009;4:e5669.
3. Zwart H. Genomics and identity: the bioinformatisation of human life. Med Health Care Philos 2009;12:125-36.
4. Levitt M, Manson N. My genes made me do it? The implications of behavioural genetics for responsibility and blame. Health Care Anal 2007;15:33-40.
5. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51.
6. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007;369:1287-301.
7. Chen PL, Yang WS. Human genetics of diabetes mellitus in Taiwan. Front Biosci 2009;14:4535-45.
8. Deng AY. Genetic basis of polygenic hypertension. Hum Mol Genet 2007;16(R2):R195-202.
9. Sequeira A, Turecki G. Genome wide gene expression studies in mood disorders. OM ICS 2006;10:444-54.
10. Ullah MF, Aatif M. The footprints of cancer development: cancer biomarkers. Cancer Treat Rev 2009;35:193-200.
11. McHugh SM, O'Donnell J, Gillen P. Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. World J Surg Oncol 2009;7:36.
12. Emery J, Barlow-Stewart K, Metcalfe SA, et al. Genetics and preventive health care. Aust Fam Physician 2007;36:808-11.
13. Siest G, Marteau JB, Maumus S, et al. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers. Eur J Pharmacol 2005;527:1-22.
14. Smith AJ, Bainbridge JW, Ali RR. Prospects for retinal gene replacement therapy. Trends Genet 2009;25:156-65.
15. Bagley J, Paez-Cortez J, Tian C, et al. Gene therapy in type 1 diabetes. Crit Rev Immunol 2008;28:301-24.
16. Rossing K, Mischak H, Dakna M, et al. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol. 2008;19:1283-90.
17. Howes JM, Keen JN, Findlay JB, et al. The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease. Diab Vasc Dis Res 2008;5:205-12.
18. Balestrieri ML, Giovane A, Mancini FP, et al. Proteomics and cardiovascular disease: an update. Curr Med Chem 2008;15:555-72.
19. Koomen JM, Haura EB, Bepler G, et al. Proteomic contributions to personalized cancer care. Mol Cell Proteomics 2008;7:1780-94.
20. Foekens JA, Wang Y, Martens JW, et al. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine. Drug Discov Today 2008;13:481-7.
21. Elias DR, Thorek DL, Chen AK, et al. In vivo imaging of cancer biomarkers using activatable molecular probes. Cancer Biomark 2008;4:287-305.
22. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 2008;299:1320-34.